Onesource Specialty Pharma posts 574.8 million rupee September-quarter profit
Onesource Specialty Pharma reported consolidated profit after tax of 574.8 million rupees for the September quarter, according to Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
India's Onesource Specialty Pharma Ltd reported consolidated profit after tax (PAT) of 574.8 million rupees for the September quarter, Reuters said.
Revenue from operations for the same period came to 5.16 billion rupees.
why it matters
The results come from a mid-sized specialty pharmaceutical company, so the impact on broader markets is limited. The figures are most relevant to investors following Indian pharma stocks and the specialty chemicals segment.
tags
instruments
sources
- Onesource Specialty Pharma Ltd Sept-Quarter Consol PAT 574.8 Million Rupees — Reuters, 27 October 2026 at 05:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗